The FDA upgraded the warning on several types of sleeping pills after 20 deaths and dozens of serious injuries
to get them through the night. Federal health officials have warned for years about the possible side effects, and now they've issued their strongest warning so far.that several popular types of prescription sleeping pills, including Ambien, Lunesta and Sonata, will now come with a prominent"black box" warning slapped on the box. The labels and patient guides will alert consumers to the possibility of some dangerous side effects.
Doctors say while side effects from sleeping pills are rare, they can lead to serious or even life-threatening harm. "These incidents can occur after the first dose of these sleep medicines or after a longer period of treatment, and can occur in patients without any history of these behaviors and even at the lowest recommended doses," FDA Acting Commissioner Ned Sharpless, M.D., said in a statement.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA: Here Are The New Warnings About Sleeping Pills Like Ambien, Lunesta, Sonata'These incidents can occur after the first dose of these sleep medicines or after a longer period of treatment, and can occur in patients without any history of these behaviors and even at the lowest recommended doses,' according to FDA Acting Commissioner Ned Sharpless, M.D.
Lire la suite »
How drugmakers come up with evocative brand names like Viagra and LunestaThere’s an art and a science to naming pharmaceutical drugs. Here’s what is embedded in the name on the label—and why
Lire la suite »
FDA COVID-19 Vaccine Process Is 'Thoughtful And Deliberate,' Says Former FDA HeadRachel Martin speaks with former Food and Drug Administration commissioner Dr. Mark McClellan about this week's FDA advisory panel on COVID-19 vaccine research.
Lire la suite »
FDA 'should have acted sooner' on e-cigarettes, vaping: FDA chiefThe head of the federal agency that regulates tobacco products said that the FDA should have acted sooner to regulate e-cigarettes.
Lire la suite »
Senior FDA official resigns in wake of 2022 infant formula shortage, acknowledges FDA communication breakdownsFDA's Deputy Commissioner for Food Policy and Response, Frank Yiannas, has announced he is resigning from his post. His departure comes in the wake of last year's infant formula shortage, throughout which Yiannas held a prominent leadership role.
Lire la suite »
Season 5 of ‘The Crown’ Is My New AmbienListen, I’m not saying it’s boring, but I’m watching it at bedtime every night and sleeping like a log, so you do the math.
Lire la suite »